simvastatin has been researched along with Cell Transformation, Neoplastic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Q; Li, Y; Xian, M; Yang, B; Ying, M | 1 |
| Byun, KS; Hwang, JW; Hyun, JJ; Jung, SW; Kim, JH; Koo, JS; Lee, SJ; Lee, SW; Seo, YS; Suh, SJ; Um, SH; Woo, SU; Yeon, JE; Yim, H; Yim, HJ | 1 |
| Kang, S; Kim, ES; Moon, A | 1 |
| Chwatal, S; Dartsch, PC; Dienstl, A; Fürst, J; Gschwentner, M; Haller, T; Lang, F; Paulmichl, M; Ritter, M; Wöll, E; Zwierzina, H | 1 |
4 other study(ies) available for simvastatin and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells.
Topics: Animals; Antibiotics, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Down-Regulation; Doxorubicin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Neoplastic Stem Cells; Osteosarcoma; RNA Interference; RNA, Small Interfering; Simvastatin; Transcription Factors; Transplantation, Heterologous | 2017 |
Synergistic effect of simvastatin plus NS398 on inhibition of proliferation and survival in hepatocellular carcinoma cell line.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cyclooxygenase 2 Inhibitors; Drug Synergism; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Neoplasms; NF-kappa B; Nitrobenzenes; Oncogene Protein v-akt; Proto-Oncogene Proteins c-bcl-2; Simvastatin; Sulfonamides | 2014 |
Simvastatin and lovastatin inhibit breast cell invasion induced by H-Ras.
Topics: Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Epithelial Cells; Female; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Lovastatin; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; ras Proteins; Signal Transduction; Simvastatin | 2009 |
Simvastatin inhibits malignant transformation following expression of the Ha-ras oncogene in NIH 3T3 fibroblasts.
Topics: 3T3 Cells; Actins; Animals; Bacterial Proteins; Calcium; Cell Division; Cell Membrane; Cell Size; Cell Transformation, Neoplastic; Cytoskeleton; Fibroblasts; Gene Expression; Genes, ras; Hydrogen-Ion Concentration; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Fluid; Ion Channels; Luminescent Proteins; Mice; Patch-Clamp Techniques; Protein Prenylation; Protein Transport; Recombinant Fusion Proteins; Simvastatin; Transfection | 2002 |